Abstract
Aims
To address questions regarding onset and progression of types 1 and 2 diabetes (T1D/T2D), surrogate imaging biomarkers for beta cell function and mass are needed. Here, we assess the potential of GPR44 as a surrogate marker for beta cells, in a direct comparison with clinically used biomarker VMAT2.
Methods
GPR44 surface availability was assessed by flow cytometry of human beta cells. RNA transcription levels in different pancreas compartments were evaluated. The density of GPR44 receptor in endocrine and exocrine tissues was assessed by the radiolabeled GPR44 ligand [3H]AZD 3825. A direct comparison with the established beta cell marker VMAT2 was performed by radiolabeled [3H]DTBZ.
Results
GPR44 was available on the cell surface, and pancreatic RNA levels were restricted to the islets of Langerhans. [3H]AZD 3825 had nanomolar affinity for GPR44 in human islets and EndoC-βH1 beta cells, and the specific binding to human beta cells was close to 50 times higher than in exocrine preparations. The endocrine-to-exocrine binding ratio was approximately 10 times higher for [3H]AZD 3825 than for [3H]DTBZ.
Conclusion
GPR44 is a highly beta cell-specific target, which potentially offers improved imaging contrast between the human beta cell and the exocrine pancreas.
Similar content being viewed by others
References
Akirav EM, Lebastchi J, Galvan EM et al (2011) Detection of β cell death in diabetes using differentially methylated circulating DNA. Proc Natl Acad Sci USA 108:19018–19023
Kanak MA, Takita M, Shahbazov R et al (2015) Evaluation of MicroRNA375 as a novel biomarker for graft damage in clinical islet transplantation. Transplantation 99:1568–1573
Locke JM, Lango Allen H, Harries LW (2014) A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells. Acta Diabetol 51:325–329
Souza F, Simpson N, Raffo A et al (2006) Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Investig 116:1506–1513
Gotthardt M, Lalyko G, van Eerd-Vismale J et al (2006) A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. Regul Pept 137:162–167
Eriksson O, Selvaraju RK, Johansson L et al (2014) Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas. J Nucl Med 55:460–465
Goland R, Freeby M, Parsey R et al (2009) 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 50:382–389
Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908–916
Brom M, Woliner-van der Weg W, Joosten L et al (2014) Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin. Diabetologia 57:950–959
Eriksson O, Espes D, Selvaraju RK et al (2014) Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas. Diabetes 63:3428–3437
Karlsson F, Antonodimitrakis P, Eriksson O (2015) Systematic screening for islet biomarkers: retrospective evaluation of clinically available neuroendocrine positron emission tomography tracers. Nucl Med Biol 42:762–769
Moran BM, Abdel-Wahab YH, Vasu S, Flatt PR, McKillop AM (2015) GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis. Acta Diabetol. doi:10.1007/s00592-015-0781-5
Lindskog C, Korsgren O, Pontén F, Eriksson JW, Johansson L, Danielsson A (2012) Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. J Proteom 75:2611–2620
Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Investig 121:3589–3597
Royer JF, Schratl P, Carrillo JJ et al (2008) A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Eur J Clin Investig 38:663–671
Goto M, Eich TM, Felldin M et al (2004) Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 78:1367–1375
Friberg AS, Stahle M, Brandhorst H, Korsgren O, Brandhorst D (2008) Human islet separation utilizing a closed automated purification system. Cell Transplant 17:1305–1313
Fagerberg L, Hallström BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom 13:397–406
Sickle (2012) A windowed adaptive trimming tool for FASTQ files using quality. https://github.com/najoshi/sickle. Accessed November 2013
Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111
Picard (2012) http://picard.sourceforge.net/. Accessed November 2013
Trapnell C, Williams BA, Pertea G et al (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511–515
Flicek P, Amode MR, Barrell D et al (2012) Ensembl 2012. Nucleic Acids Res 40:D84–D90
Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11:R106
R CoreTeam (2013) R: a language and environment for statistical computing. R foundation for statistical computing. http://www.R-project.org/. Accessed November 2013
Gregory RW (2012) Gplots: various R programming tools for plotting data. R package version 2.11.0. http://CRAN.R-project.org/package=gplots. Accessed November 2013
Tsao HH, Skovronsky DM, Lin KJ, Yen TC, Wey SP, Kung MP (2011) Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas. Nucl Med Biol 38:1029–1034
Jahan M, Eriksson O, Johnström P et al (2011) Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET. EJNMMI Res 1:33
Eriksson O, Jahan M, Johnström P et al (2010) In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol 37:357–363
Fagerholm V, Mikkola KK, Ishizu T et al (2010) Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 51:1439–1446
Tsao HH, Skovronsky DM, Lin KJ (2011) Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas. Nucl Med Biol 38:1029–1034
The Human Protein Atlas (2015) http://www.proteinatlas.org/ENSG00000183134-PTGDR2/tissue/cerebral+cortex. Accessed August 2015
Harris PE, Farwell MD, Ichise M (2013) PET quantification of pancreatic VMAT 2 binding using (+) and (−) enantiomers of [(1)(8)F]FP-DTBZ in baboons. Nucl Med Biol 40:60–64
Zubieta JK, Gorelick DA, Stauffer R et al (1996) Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 2:1225–1229
Acknowledgments
The study was supported by grants from JDRF, Diabetesfonden, Barndiabetesfonden, and Tore Nilssons Foundation for Medical Research. O.E.s position was supported by ExoDiab (Excellence of Diabetes Research in Sweden) and O.K.s position was supported by the National Institutes of Health (2U01AI065192-06).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Paul Czernichow is an employee of EndoCells. The remaining authors report no conflicts of interest.
Ethical standard
All work involving human tissue was conducted according to the principles expressed in the Declaration of Helsinki and in the European Council’s Convention on Human Rights and Biomedicine. Consent for organ donation (for clinical transplantation and for use in research) was obtained from the relatives of the deceased donors by the donor’s physicians and documented in the medical records of the deceased subject. The study was approved by the Regional Ethics Committee in Uppsala, Sweden (http://www.epn.se) according to the Act concerning the Ethical Review of Research Involving Humans (2003:460), Permit Number: Dnr 2009/371 (from April 10, 2013).
Human and animal rights disclosure
This article does not contain any studies with human or animal subjects performed by any of the authors.
Informed consent
None.
Additional information
Managed by Antonio Secchi.
Electronic supplementary material
Below is the link to the electronic supplementary material.
592_2015_811_MOESM1_ESM.pdf
Supplementary Fig. 1. Representative saturation binding experiments to assess affinity (Kd) and receptor density (Bmax) of [3H]AZD 3825 (A-C) and [3H]DTBZ (D-E). Homogenized human pancreatic endocrine (A, D) or exocrine (B, E) preparations was used. [3H]AZD 3825 binding to pure human beta cells was assessed by EndoC-βH1 cell homogenates (C). Supplementary material 1 (PDF 55 kb)
Rights and permissions
About this article
Cite this article
Hellström-Lindahl, E., Danielsson, A., Ponten, F. et al. GPR44 is a pancreatic protein restricted to the human beta cell. Acta Diabetol 53, 413–421 (2016). https://doi.org/10.1007/s00592-015-0811-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-015-0811-3